American Cancer Society awards research grant to WVU
MORGANTOWN, W.Va. – The WVU Mary Babb Randolph Cancer Center will use a three-year, $180,000 American Cancer Society (ACS) grant to support six junior faculty members engaged in cancer research.
“We are grateful to the ACS for supporting the next generation of cancer researchers,” Scot Remick, M.D., Cancer Center director, said. “This award will give our young scientists an opportunity to seek competitive funding for pilot projects involving population studies and lab-based research. Thanks to our partnership with the ACS we are continuing to keep cancer research moving forward.”
Upon approving WVU’s grant application, the ACS review committee rated WVU’s cancer program as “outstanding” and likely to contribute to the establishment of a National Cancer Institute-designated cancer center in a region that has considerable cancer disparities and high rates of cancer in the population.
“WVU has some of the best and brightest researchers in the country, and we are proud to partner with them in the fight against cancer,” Kevin Tephabock, state vice-president of the American Cancer Society, said. “The ACS has provided WVU well over $4 million over the years for cancer research.”
WVU’s latest grant is one of 16 awarded nationwide by the ACS and is the only such grant awarded in West Virginia.
The Cancer Center has received applications from junior faculty seeking the funding and will announce the winners next month.
One ongoing cancer research project at WVU funded through a previously awarded ACS grant is led by Jun Liu, M.D., Ph.D., associate professor in the Department of Physiology and Pharmacology. Dr. Liu is investigating the molecular mechanism of cell polarity and directional migration, a key step toward blood vessel development that is critical for cancer growth and metastasis.
“We are grateful to the ACS for supporting the next generation of cancer researchers,” Scot Remick, M.D., Cancer Center director, said. “This award will give our young scientists an opportunity to seek competitive funding for pilot projects involving population studies and lab-based research. Thanks to our partnership with the ACS we are continuing to keep cancer research moving forward.”
Upon approving WVU’s grant application, the ACS review committee rated WVU’s cancer program as “outstanding” and likely to contribute to the establishment of a National Cancer Institute-designated cancer center in a region that has considerable cancer disparities and high rates of cancer in the population.
“WVU has some of the best and brightest researchers in the country, and we are proud to partner with them in the fight against cancer,” Kevin Tephabock, state vice-president of the American Cancer Society, said. “The ACS has provided WVU well over $4 million over the years for cancer research.”
WVU’s latest grant is one of 16 awarded nationwide by the ACS and is the only such grant awarded in West Virginia.
The Cancer Center has received applications from junior faculty seeking the funding and will announce the winners next month.
One ongoing cancer research project at WVU funded through a previously awarded ACS grant is led by Jun Liu, M.D., Ph.D., associate professor in the Department of Physiology and Pharmacology. Dr. Liu is investigating the molecular mechanism of cell polarity and directional migration, a key step toward blood vessel development that is critical for cancer growth and metastasis.